nodes	percent_of_prediction	percent_of_DWPC	metapath
Fentanyl—CYP3A7—Vincristine—muscle cancer	0.102	0.154	CbGbCtD
Fentanyl—CYP3A7-CYP3A51P—Vincristine—muscle cancer	0.102	0.154	CbGbCtD
Fentanyl—ABCB1—Dactinomycin—muscle cancer	0.0811	0.122	CbGbCtD
Fentanyl—CYP3A5—Vincristine—muscle cancer	0.0768	0.115	CbGbCtD
Fentanyl—CYP3A5—Etoposide—muscle cancer	0.0703	0.106	CbGbCtD
Fentanyl—ABCB1—Vincristine—muscle cancer	0.05	0.075	CbGbCtD
Fentanyl—ABCB1—Etoposide—muscle cancer	0.0458	0.0687	CbGbCtD
Fentanyl—ABCB1—Doxorubicin—muscle cancer	0.0312	0.0469	CbGbCtD
Fentanyl—ABCB1—Methotrexate—muscle cancer	0.0302	0.0454	CbGbCtD
Fentanyl—CYP3A4—Vincristine—muscle cancer	0.0299	0.0449	CbGbCtD
Fentanyl—CYP3A4—Etoposide—muscle cancer	0.0274	0.0412	CbGbCtD
Fentanyl—CYP3A4—Doxorubicin—muscle cancer	0.0187	0.0281	CbGbCtD
Fentanyl—Body temperature increased—Vincristine—muscle cancer	0.000306	0.000917	CcSEcCtD
Fentanyl—Abdominal pain—Vincristine—muscle cancer	0.000306	0.000917	CcSEcCtD
Fentanyl—Skin disorder—Etoposide—muscle cancer	0.000305	0.000913	CcSEcCtD
Fentanyl—Erectile dysfunction—Methotrexate—muscle cancer	0.000304	0.000912	CcSEcCtD
Fentanyl—Hyperhidrosis—Etoposide—muscle cancer	0.000303	0.000909	CcSEcCtD
Fentanyl—Orthostatic hypotension—Doxorubicin—muscle cancer	0.000302	0.000906	CcSEcCtD
Fentanyl—Abdominal pain upper—Doxorubicin—muscle cancer	0.000302	0.000906	CcSEcCtD
Fentanyl—Hypokalaemia—Doxorubicin—muscle cancer	0.000301	0.000903	CcSEcCtD
Fentanyl—Breast disorder—Doxorubicin—muscle cancer	0.000299	0.000896	CcSEcCtD
Fentanyl—Anorexia—Etoposide—muscle cancer	0.000299	0.000896	CcSEcCtD
Fentanyl—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	0.000298	0.000893	CcSEcCtD
Fentanyl—Diarrhoea—Dactinomycin—muscle cancer	0.000297	0.000888	CcSEcCtD
Fentanyl—Pneumonia—Methotrexate—muscle cancer	0.000296	0.000888	CcSEcCtD
Fentanyl—Nasopharyngitis—Doxorubicin—muscle cancer	0.000296	0.000887	CcSEcCtD
Fentanyl—Drowsiness—Methotrexate—muscle cancer	0.000295	0.000883	CcSEcCtD
Fentanyl—Infestation NOS—Methotrexate—muscle cancer	0.000295	0.000883	CcSEcCtD
Fentanyl—Infestation—Methotrexate—muscle cancer	0.000295	0.000883	CcSEcCtD
Fentanyl—Depression—Methotrexate—muscle cancer	0.000294	0.00088	CcSEcCtD
Fentanyl—Hypotension—Etoposide—muscle cancer	0.000293	0.000878	CcSEcCtD
Fentanyl—Gastritis—Doxorubicin—muscle cancer	0.000293	0.000878	CcSEcCtD
Fentanyl—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.000292	0.000875	CcSEcCtD
Fentanyl—Muscular weakness—Doxorubicin—muscle cancer	0.000292	0.000875	CcSEcCtD
Fentanyl—Renal failure—Methotrexate—muscle cancer	0.00029	0.000868	CcSEcCtD
Fentanyl—Abdominal distension—Doxorubicin—muscle cancer	0.000288	0.000863	CcSEcCtD
Fentanyl—Stomatitis—Methotrexate—muscle cancer	0.000287	0.00086	CcSEcCtD
Fentanyl—Conjunctivitis—Methotrexate—muscle cancer	0.000286	0.000858	CcSEcCtD
Fentanyl—Asthma—Doxorubicin—muscle cancer	0.000286	0.000857	CcSEcCtD
Fentanyl—Influenza—Doxorubicin—muscle cancer	0.000286	0.000857	CcSEcCtD
Fentanyl—Dysphagia—Doxorubicin—muscle cancer	0.000286	0.000857	CcSEcCtD
Fentanyl—Hypersensitivity—Vincristine—muscle cancer	0.000285	0.000855	CcSEcCtD
Fentanyl—Sweating—Methotrexate—muscle cancer	0.000283	0.000846	CcSEcCtD
Fentanyl—Paraesthesia—Etoposide—muscle cancer	0.000282	0.000844	CcSEcCtD
Fentanyl—Haematuria—Methotrexate—muscle cancer	0.000281	0.000842	CcSEcCtD
Fentanyl—Dyspnoea—Etoposide—muscle cancer	0.00028	0.000838	CcSEcCtD
Fentanyl—Somnolence—Etoposide—muscle cancer	0.000279	0.000836	CcSEcCtD
Fentanyl—Angina pectoris—Doxorubicin—muscle cancer	0.000279	0.000835	CcSEcCtD
Fentanyl—Hepatobiliary disease—Methotrexate—muscle cancer	0.000279	0.000835	CcSEcCtD
Fentanyl—Epistaxis—Methotrexate—muscle cancer	0.000278	0.000833	CcSEcCtD
Fentanyl—Asthenia—Vincristine—muscle cancer	0.000278	0.000832	CcSEcCtD
Fentanyl—Vomiting—Dactinomycin—muscle cancer	0.000276	0.000826	CcSEcCtD
Fentanyl—Bronchitis—Doxorubicin—muscle cancer	0.000275	0.000824	CcSEcCtD
Fentanyl—Rash—Dactinomycin—muscle cancer	0.000273	0.000819	CcSEcCtD
Fentanyl—Decreased appetite—Etoposide—muscle cancer	0.000273	0.000817	CcSEcCtD
Fentanyl—Pancytopenia—Doxorubicin—muscle cancer	0.000272	0.000814	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Etoposide—muscle cancer	0.000271	0.000811	CcSEcCtD
Fentanyl—Fatigue—Etoposide—muscle cancer	0.000271	0.00081	CcSEcCtD
Fentanyl—Pain—Etoposide—muscle cancer	0.000268	0.000804	CcSEcCtD
Fentanyl—Constipation—Etoposide—muscle cancer	0.000268	0.000804	CcSEcCtD
Fentanyl—Dysuria—Doxorubicin—muscle cancer	0.000268	0.000802	CcSEcCtD
Fentanyl—Neutropenia—Doxorubicin—muscle cancer	0.000268	0.000802	CcSEcCtD
Fentanyl—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.000266	0.000797	CcSEcCtD
Fentanyl—Haemoglobin—Methotrexate—muscle cancer	0.000266	0.000796	CcSEcCtD
Fentanyl—Diarrhoea—Vincristine—muscle cancer	0.000265	0.000794	CcSEcCtD
Fentanyl—Haemorrhage—Methotrexate—muscle cancer	0.000265	0.000792	CcSEcCtD
Fentanyl—Pollakiuria—Doxorubicin—muscle cancer	0.000264	0.000792	CcSEcCtD
Fentanyl—Pharyngitis—Methotrexate—muscle cancer	0.000263	0.000786	CcSEcCtD
Fentanyl—Urinary tract disorder—Methotrexate—muscle cancer	0.000261	0.000783	CcSEcCtD
Fentanyl—Weight increased—Doxorubicin—muscle cancer	0.00026	0.00078	CcSEcCtD
Fentanyl—Urethral disorder—Methotrexate—muscle cancer	0.000259	0.000777	CcSEcCtD
Fentanyl—Weight decreased—Doxorubicin—muscle cancer	0.000259	0.000776	CcSEcCtD
Fentanyl—Feeling abnormal—Etoposide—muscle cancer	0.000259	0.000774	CcSEcCtD
Fentanyl—Hyperglycaemia—Doxorubicin—muscle cancer	0.000258	0.000773	CcSEcCtD
Fentanyl—Nausea—Dactinomycin—muscle cancer	0.000258	0.000771	CcSEcCtD
Fentanyl—Pneumonia—Doxorubicin—muscle cancer	0.000257	0.000769	CcSEcCtD
Fentanyl—Gastrointestinal pain—Etoposide—muscle cancer	0.000257	0.000769	CcSEcCtD
Fentanyl—Dizziness—Vincristine—muscle cancer	0.000256	0.000767	CcSEcCtD
Fentanyl—Infestation—Doxorubicin—muscle cancer	0.000255	0.000764	CcSEcCtD
Fentanyl—Infestation NOS—Doxorubicin—muscle cancer	0.000255	0.000764	CcSEcCtD
Fentanyl—Drowsiness—Doxorubicin—muscle cancer	0.000255	0.000764	CcSEcCtD
Fentanyl—Visual impairment—Methotrexate—muscle cancer	0.000255	0.000764	CcSEcCtD
Fentanyl—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.000253	0.000758	CcSEcCtD
Fentanyl—Renal failure—Doxorubicin—muscle cancer	0.000251	0.000751	CcSEcCtD
Fentanyl—Erythema multiforme—Methotrexate—muscle cancer	0.00025	0.000749	CcSEcCtD
Fentanyl—Neuropathy peripheral—Doxorubicin—muscle cancer	0.00025	0.000749	CcSEcCtD
Fentanyl—Urticaria—Etoposide—muscle cancer	0.000249	0.000747	CcSEcCtD
Fentanyl—Stomatitis—Doxorubicin—muscle cancer	0.000249	0.000745	CcSEcCtD
Fentanyl—Jaundice—Doxorubicin—muscle cancer	0.000249	0.000745	CcSEcCtD
Fentanyl—Abdominal pain—Etoposide—muscle cancer	0.000248	0.000743	CcSEcCtD
Fentanyl—Body temperature increased—Etoposide—muscle cancer	0.000248	0.000743	CcSEcCtD
Fentanyl—Urinary tract infection—Doxorubicin—muscle cancer	0.000248	0.000743	CcSEcCtD
Fentanyl—Conjunctivitis—Doxorubicin—muscle cancer	0.000248	0.000743	CcSEcCtD
Fentanyl—Eye disorder—Methotrexate—muscle cancer	0.000247	0.00074	CcSEcCtD
Fentanyl—Tinnitus—Methotrexate—muscle cancer	0.000247	0.000739	CcSEcCtD
Fentanyl—Vomiting—Vincristine—muscle cancer	0.000246	0.000738	CcSEcCtD
Fentanyl—Cardiac disorder—Methotrexate—muscle cancer	0.000246	0.000735	CcSEcCtD
Fentanyl—Sweating—Doxorubicin—muscle cancer	0.000245	0.000733	CcSEcCtD
Fentanyl—Rash—Vincristine—muscle cancer	0.000244	0.000732	CcSEcCtD
Fentanyl—Dermatitis—Vincristine—muscle cancer	0.000244	0.000731	CcSEcCtD
Fentanyl—Haematuria—Doxorubicin—muscle cancer	0.000243	0.000729	CcSEcCtD
Fentanyl—Headache—Vincristine—muscle cancer	0.000243	0.000727	CcSEcCtD
Fentanyl—Hepatobiliary disease—Doxorubicin—muscle cancer	0.000241	0.000723	CcSEcCtD
Fentanyl—Epistaxis—Doxorubicin—muscle cancer	0.000241	0.000721	CcSEcCtD
Fentanyl—Angiopathy—Methotrexate—muscle cancer	0.00024	0.000719	CcSEcCtD
Fentanyl—Sinusitis—Doxorubicin—muscle cancer	0.000239	0.000717	CcSEcCtD
Fentanyl—Immune system disorder—Methotrexate—muscle cancer	0.000239	0.000716	CcSEcCtD
Fentanyl—Mediastinal disorder—Methotrexate—muscle cancer	0.000238	0.000714	CcSEcCtD
Fentanyl—Chills—Methotrexate—muscle cancer	0.000237	0.000711	CcSEcCtD
Fentanyl—Alopecia—Methotrexate—muscle cancer	0.000234	0.0007	CcSEcCtD
Fentanyl—Bradycardia—Doxorubicin—muscle cancer	0.000233	0.000698	CcSEcCtD
Fentanyl—Mental disorder—Methotrexate—muscle cancer	0.000232	0.000694	CcSEcCtD
Fentanyl—Hypersensitivity—Etoposide—muscle cancer	0.000231	0.000692	CcSEcCtD
Fentanyl—Erythema—Methotrexate—muscle cancer	0.00023	0.00069	CcSEcCtD
Fentanyl—Malnutrition—Methotrexate—muscle cancer	0.00023	0.00069	CcSEcCtD
Fentanyl—Haemoglobin—Doxorubicin—muscle cancer	0.00023	0.00069	CcSEcCtD
Fentanyl—Nausea—Vincristine—muscle cancer	0.00023	0.000689	CcSEcCtD
Fentanyl—Rhinitis—Doxorubicin—muscle cancer	0.00023	0.000688	CcSEcCtD
Fentanyl—Haemorrhage—Doxorubicin—muscle cancer	0.000229	0.000686	CcSEcCtD
Fentanyl—Hypoaesthesia—Doxorubicin—muscle cancer	0.000228	0.000683	CcSEcCtD
Fentanyl—Pharyngitis—Doxorubicin—muscle cancer	0.000227	0.000681	CcSEcCtD
Fentanyl—Urinary tract disorder—Doxorubicin—muscle cancer	0.000226	0.000678	CcSEcCtD
Fentanyl—Oedema peripheral—Doxorubicin—muscle cancer	0.000226	0.000676	CcSEcCtD
Fentanyl—Dysgeusia—Methotrexate—muscle cancer	0.000226	0.000675	CcSEcCtD
Fentanyl—Asthenia—Etoposide—muscle cancer	0.000225	0.000674	CcSEcCtD
Fentanyl—Connective tissue disorder—Doxorubicin—muscle cancer	0.000225	0.000674	CcSEcCtD
Fentanyl—Urethral disorder—Doxorubicin—muscle cancer	0.000225	0.000673	CcSEcCtD
Fentanyl—Back pain—Methotrexate—muscle cancer	0.000223	0.000667	CcSEcCtD
Fentanyl—Pruritus—Etoposide—muscle cancer	0.000222	0.000665	CcSEcCtD
Fentanyl—Visual impairment—Doxorubicin—muscle cancer	0.000221	0.000661	CcSEcCtD
Fentanyl—Vision blurred—Methotrexate—muscle cancer	0.000217	0.00065	CcSEcCtD
Fentanyl—Erythema multiforme—Doxorubicin—muscle cancer	0.000217	0.000649	CcSEcCtD
Fentanyl—Diarrhoea—Etoposide—muscle cancer	0.000215	0.000643	CcSEcCtD
Fentanyl—Eye disorder—Doxorubicin—muscle cancer	0.000214	0.000641	CcSEcCtD
Fentanyl—Ill-defined disorder—Methotrexate—muscle cancer	0.000214	0.00064	CcSEcCtD
Fentanyl—Tinnitus—Doxorubicin—muscle cancer	0.000214	0.00064	CcSEcCtD
Fentanyl—Anaemia—Methotrexate—muscle cancer	0.000213	0.000638	CcSEcCtD
Fentanyl—Flushing—Doxorubicin—muscle cancer	0.000213	0.000637	CcSEcCtD
Fentanyl—Cardiac disorder—Doxorubicin—muscle cancer	0.000213	0.000637	CcSEcCtD
Fentanyl—Angiopathy—Doxorubicin—muscle cancer	0.000208	0.000623	CcSEcCtD
Fentanyl—Malaise—Methotrexate—muscle cancer	0.000208	0.000622	CcSEcCtD
Fentanyl—Dizziness—Etoposide—muscle cancer	0.000208	0.000621	CcSEcCtD
Fentanyl—Immune system disorder—Doxorubicin—muscle cancer	0.000207	0.00062	CcSEcCtD
Fentanyl—Vertigo—Methotrexate—muscle cancer	0.000207	0.00062	CcSEcCtD
Fentanyl—Mediastinal disorder—Doxorubicin—muscle cancer	0.000206	0.000618	CcSEcCtD
Fentanyl—Leukopenia—Methotrexate—muscle cancer	0.000206	0.000617	CcSEcCtD
Fentanyl—Chills—Doxorubicin—muscle cancer	0.000206	0.000616	CcSEcCtD
Fentanyl—Arrhythmia—Doxorubicin—muscle cancer	0.000205	0.000613	CcSEcCtD
Fentanyl—Alopecia—Doxorubicin—muscle cancer	0.000202	0.000606	CcSEcCtD
Fentanyl—Cough—Methotrexate—muscle cancer	0.000201	0.000602	CcSEcCtD
Fentanyl—Mental disorder—Doxorubicin—muscle cancer	0.000201	0.000601	CcSEcCtD
Fentanyl—Convulsion—Methotrexate—muscle cancer	0.0002	0.000598	CcSEcCtD
Fentanyl—Vomiting—Etoposide—muscle cancer	0.0002	0.000598	CcSEcCtD
Fentanyl—Malnutrition—Doxorubicin—muscle cancer	0.000199	0.000597	CcSEcCtD
Fentanyl—Erythema—Doxorubicin—muscle cancer	0.000199	0.000597	CcSEcCtD
Fentanyl—Rash—Etoposide—muscle cancer	0.000198	0.000593	CcSEcCtD
Fentanyl—Dermatitis—Etoposide—muscle cancer	0.000198	0.000592	CcSEcCtD
Fentanyl—Headache—Etoposide—muscle cancer	0.000197	0.000589	CcSEcCtD
Fentanyl—Flatulence—Doxorubicin—muscle cancer	0.000197	0.000589	CcSEcCtD
Fentanyl—Myalgia—Methotrexate—muscle cancer	0.000196	0.000587	CcSEcCtD
Fentanyl—Arthralgia—Methotrexate—muscle cancer	0.000196	0.000587	CcSEcCtD
Fentanyl—Chest pain—Methotrexate—muscle cancer	0.000196	0.000587	CcSEcCtD
Fentanyl—Tension—Doxorubicin—muscle cancer	0.000196	0.000586	CcSEcCtD
Fentanyl—Dysgeusia—Doxorubicin—muscle cancer	0.000195	0.000585	CcSEcCtD
Fentanyl—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000195	0.000583	CcSEcCtD
Fentanyl—Discomfort—Methotrexate—muscle cancer	0.000194	0.00058	CcSEcCtD
Fentanyl—Nervousness—Doxorubicin—muscle cancer	0.000194	0.00058	CcSEcCtD
Fentanyl—Back pain—Doxorubicin—muscle cancer	0.000193	0.000578	CcSEcCtD
Fentanyl—Muscle spasms—Doxorubicin—muscle cancer	0.000192	0.000574	CcSEcCtD
Fentanyl—Confusional state—Methotrexate—muscle cancer	0.00019	0.000568	CcSEcCtD
Fentanyl—Anaphylactic shock—Methotrexate—muscle cancer	0.000188	0.000563	CcSEcCtD
Fentanyl—Vision blurred—Doxorubicin—muscle cancer	0.000188	0.000563	CcSEcCtD
Fentanyl—Infection—Methotrexate—muscle cancer	0.000187	0.000559	CcSEcCtD
Fentanyl—Nausea—Etoposide—muscle cancer	0.000186	0.000558	CcSEcCtD
Fentanyl—Ill-defined disorder—Doxorubicin—muscle cancer	0.000185	0.000554	CcSEcCtD
Fentanyl—Nervous system disorder—Methotrexate—muscle cancer	0.000184	0.000552	CcSEcCtD
Fentanyl—Anaemia—Doxorubicin—muscle cancer	0.000184	0.000552	CcSEcCtD
Fentanyl—Thrombocytopenia—Methotrexate—muscle cancer	0.000184	0.000551	CcSEcCtD
Fentanyl—Agitation—Doxorubicin—muscle cancer	0.000183	0.000549	CcSEcCtD
Fentanyl—Skin disorder—Methotrexate—muscle cancer	0.000183	0.000547	CcSEcCtD
Fentanyl—Hyperhidrosis—Methotrexate—muscle cancer	0.000182	0.000544	CcSEcCtD
Fentanyl—Malaise—Doxorubicin—muscle cancer	0.00018	0.000539	CcSEcCtD
Fentanyl—Vertigo—Doxorubicin—muscle cancer	0.000179	0.000537	CcSEcCtD
Fentanyl—Anorexia—Methotrexate—muscle cancer	0.000179	0.000537	CcSEcCtD
Fentanyl—Syncope—Doxorubicin—muscle cancer	0.000179	0.000536	CcSEcCtD
Fentanyl—Leukopenia—Doxorubicin—muscle cancer	0.000179	0.000535	CcSEcCtD
Fentanyl—Palpitations—Doxorubicin—muscle cancer	0.000176	0.000528	CcSEcCtD
Fentanyl—Hypotension—Methotrexate—muscle cancer	0.000176	0.000526	CcSEcCtD
Fentanyl—Loss of consciousness—Doxorubicin—muscle cancer	0.000175	0.000525	CcSEcCtD
Fentanyl—Cough—Doxorubicin—muscle cancer	0.000174	0.000521	CcSEcCtD
Fentanyl—Convulsion—Doxorubicin—muscle cancer	0.000173	0.000517	CcSEcCtD
Fentanyl—Hypertension—Doxorubicin—muscle cancer	0.000172	0.000516	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000171	0.000513	CcSEcCtD
Fentanyl—Insomnia—Methotrexate—muscle cancer	0.00017	0.000509	CcSEcCtD
Fentanyl—Arthralgia—Doxorubicin—muscle cancer	0.00017	0.000508	CcSEcCtD
Fentanyl—Myalgia—Doxorubicin—muscle cancer	0.00017	0.000508	CcSEcCtD
Fentanyl—Chest pain—Doxorubicin—muscle cancer	0.00017	0.000508	CcSEcCtD
Fentanyl—Anxiety—Doxorubicin—muscle cancer	0.000169	0.000507	CcSEcCtD
Fentanyl—Paraesthesia—Methotrexate—muscle cancer	0.000169	0.000505	CcSEcCtD
Fentanyl—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000169	0.000505	CcSEcCtD
Fentanyl—Discomfort—Doxorubicin—muscle cancer	0.000168	0.000502	CcSEcCtD
Fentanyl—Dyspnoea—Methotrexate—muscle cancer	0.000168	0.000502	CcSEcCtD
Fentanyl—Somnolence—Methotrexate—muscle cancer	0.000167	0.0005	CcSEcCtD
Fentanyl—Dry mouth—Doxorubicin—muscle cancer	0.000166	0.000497	CcSEcCtD
Fentanyl—Dyspepsia—Methotrexate—muscle cancer	0.000165	0.000496	CcSEcCtD
Fentanyl—Confusional state—Doxorubicin—muscle cancer	0.000164	0.000492	CcSEcCtD
Fentanyl—Decreased appetite—Methotrexate—muscle cancer	0.000163	0.000489	CcSEcCtD
Fentanyl—Oedema—Doxorubicin—muscle cancer	0.000163	0.000487	CcSEcCtD
Fentanyl—Anaphylactic shock—Doxorubicin—muscle cancer	0.000163	0.000487	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000162	0.000486	CcSEcCtD
Fentanyl—Fatigue—Methotrexate—muscle cancer	0.000162	0.000485	CcSEcCtD
Fentanyl—Infection—Doxorubicin—muscle cancer	0.000162	0.000484	CcSEcCtD
Fentanyl—Pain—Methotrexate—muscle cancer	0.000161	0.000481	CcSEcCtD
Fentanyl—Shock—Doxorubicin—muscle cancer	0.00016	0.00048	CcSEcCtD
Fentanyl—Nervous system disorder—Doxorubicin—muscle cancer	0.00016	0.000478	CcSEcCtD
Fentanyl—Thrombocytopenia—Doxorubicin—muscle cancer	0.000159	0.000477	CcSEcCtD
Fentanyl—Tachycardia—Doxorubicin—muscle cancer	0.000159	0.000476	CcSEcCtD
Fentanyl—Skin disorder—Doxorubicin—muscle cancer	0.000158	0.000473	CcSEcCtD
Fentanyl—Hyperhidrosis—Doxorubicin—muscle cancer	0.000157	0.000471	CcSEcCtD
Fentanyl—Anorexia—Doxorubicin—muscle cancer	0.000155	0.000465	CcSEcCtD
Fentanyl—Feeling abnormal—Methotrexate—muscle cancer	0.000155	0.000464	CcSEcCtD
Fentanyl—Gastrointestinal pain—Methotrexate—muscle cancer	0.000154	0.00046	CcSEcCtD
Fentanyl—Hypotension—Doxorubicin—muscle cancer	0.000152	0.000455	CcSEcCtD
Fentanyl—Urticaria—Methotrexate—muscle cancer	0.000149	0.000447	CcSEcCtD
Fentanyl—Abdominal pain—Methotrexate—muscle cancer	0.000149	0.000445	CcSEcCtD
Fentanyl—Body temperature increased—Methotrexate—muscle cancer	0.000149	0.000445	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000148	0.000444	CcSEcCtD
Fentanyl—Insomnia—Doxorubicin—muscle cancer	0.000147	0.000441	CcSEcCtD
Fentanyl—Paraesthesia—Doxorubicin—muscle cancer	0.000146	0.000438	CcSEcCtD
Fentanyl—Dyspnoea—Doxorubicin—muscle cancer	0.000145	0.000435	CcSEcCtD
Fentanyl—Somnolence—Doxorubicin—muscle cancer	0.000145	0.000433	CcSEcCtD
Fentanyl—Dyspepsia—Doxorubicin—muscle cancer	0.000143	0.000429	CcSEcCtD
Fentanyl—Decreased appetite—Doxorubicin—muscle cancer	0.000141	0.000424	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000141	0.000421	CcSEcCtD
Fentanyl—Fatigue—Doxorubicin—muscle cancer	0.00014	0.00042	CcSEcCtD
Fentanyl—Constipation—Doxorubicin—muscle cancer	0.000139	0.000417	CcSEcCtD
Fentanyl—Pain—Doxorubicin—muscle cancer	0.000139	0.000417	CcSEcCtD
Fentanyl—Hypersensitivity—Methotrexate—muscle cancer	0.000138	0.000415	CcSEcCtD
Fentanyl—Asthenia—Methotrexate—muscle cancer	0.000135	0.000404	CcSEcCtD
Fentanyl—Feeling abnormal—Doxorubicin—muscle cancer	0.000134	0.000402	CcSEcCtD
Fentanyl—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000133	0.000399	CcSEcCtD
Fentanyl—Pruritus—Methotrexate—muscle cancer	0.000133	0.000398	CcSEcCtD
Fentanyl—Urticaria—Doxorubicin—muscle cancer	0.000129	0.000387	CcSEcCtD
Fentanyl—Abdominal pain—Doxorubicin—muscle cancer	0.000129	0.000385	CcSEcCtD
Fentanyl—Body temperature increased—Doxorubicin—muscle cancer	0.000129	0.000385	CcSEcCtD
Fentanyl—Diarrhoea—Methotrexate—muscle cancer	0.000129	0.000385	CcSEcCtD
Fentanyl—Dizziness—Methotrexate—muscle cancer	0.000124	0.000372	CcSEcCtD
Fentanyl—Hypersensitivity—Doxorubicin—muscle cancer	0.00012	0.000359	CcSEcCtD
Fentanyl—Vomiting—Methotrexate—muscle cancer	0.00012	0.000358	CcSEcCtD
Fentanyl—Rash—Methotrexate—muscle cancer	0.000119	0.000355	CcSEcCtD
Fentanyl—Dermatitis—Methotrexate—muscle cancer	0.000118	0.000355	CcSEcCtD
Fentanyl—Headache—Methotrexate—muscle cancer	0.000118	0.000353	CcSEcCtD
Fentanyl—Asthenia—Doxorubicin—muscle cancer	0.000117	0.00035	CcSEcCtD
Fentanyl—Pruritus—Doxorubicin—muscle cancer	0.000115	0.000345	CcSEcCtD
Fentanyl—Nausea—Methotrexate—muscle cancer	0.000112	0.000334	CcSEcCtD
Fentanyl—Diarrhoea—Doxorubicin—muscle cancer	0.000111	0.000334	CcSEcCtD
Fentanyl—Dizziness—Doxorubicin—muscle cancer	0.000108	0.000322	CcSEcCtD
Fentanyl—Vomiting—Doxorubicin—muscle cancer	0.000103	0.00031	CcSEcCtD
Fentanyl—Rash—Doxorubicin—muscle cancer	0.000103	0.000307	CcSEcCtD
Fentanyl—Dermatitis—Doxorubicin—muscle cancer	0.000103	0.000307	CcSEcCtD
Fentanyl—Headache—Doxorubicin—muscle cancer	0.000102	0.000305	CcSEcCtD
Fentanyl—Nausea—Doxorubicin—muscle cancer	9.67e-05	0.00029	CcSEcCtD
